Selected Grants
A Phase 3 Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy/Safety of Maridebart Cafraglutide on Mortality, Morbidity in Participants Living With Heart Failure With Preserved or Mildly Reduced Ejection Fraction Obesity
Clinical TrialPrincipal Investigator · Awarded by Amgen, Inc. · 2025 - 2032REFOCUS-HTN US
Clinical TrialPrincipal Investigator · Awarded by AstraZeneca Pharmaceuticals, LP · 2025 - 2027Post-Hoc Analysis of the TRANSFORM Trial
ResearchPrincipal Investigator · Awarded by University of Texas - Southwestern · 2025 - 2026Assessing Patient Experiences with 'Food is Medicine' to Improve Congestive Heart Failure Outcomes: A Qualitative Study
ResearchCo Investigator · Awarded by American Heart Association · 2025 - 2026PARACOR-19
Clinical TrialPrincipal Investigator · Awarded by Novartis Pharmaceuticals Corporation · 2021 - 2026Identifying barriers to and optiMizing in-hosPitaL usE of evidenced-based Medical thErapies for patieNTs with Cardio-Renal-Metabolic Disease (IMPLEMENT-CRM)
Clinical TrialPrincipal Investigator · Awarded by Boehringer Ingelheim Pharmaceuticals, Inc. · 2023 - 2026Use and Effectiveness of Outpatient Intravenous Diuretic Therapy as Treatment for Worsening Heart Failure
ResearchPrincipal Investigator · Awarded by American Heart Association · 2022 - 2026Otsuka HF Ph2 POC
Clinical TrialPrincipal Investigator · Awarded by Otsuka Pharmaceutical Development & Commercialization, Inc. · 2024 - 2025Goals-HF
Clinical TrialPrincipal Investigator · Awarded by Tricog Health Inc. · 2023 - 2025TRANSFORM-HF DCC
ResearchCo Investigator · Awarded by National Institutes of Health · 2017 - 2024Comparison of Dyspnea Measurement Instruments in Acute Heart Failure
Clinical TrialPrincipal Investigator · Awarded by Heart Failure Society of America · 2017 - 2019External Relationships
- Amgen, Inc.
- AstraZeneca
- Bayer
- Boehringer Ingelheim/Lilly alliance
- Boehringer Ingleheim
- Bristol-Myers Squibb
- CSL Vifor
- Corcept Therapeutics
- Corteria Pharmaceuticals
- Cytokinetics, Inc.
- Lexicon Pharmaceuticals, Inc.
- Merck Sharpe & Dohme (Merck & Co, USA)
- Novo Nordisk
- Otsuka Pharmaceuticals
- Pfizer Inc.
- PharmaIN
- Roche Diagnostics
- Sanofi
- Tricog Health
- scPharma
This faculty member (or a member of their immediate family) has reported outside activities with the companies, institutions, or organizations listed above. This information is available to institutional leadership and, when appropriate, management plans are in place to address potential conflicts of interest.